Xuebijing as a potential therapeutic option for septic shock: the need for rigorous evaluation of life-threatening adverse effects.

Honoré, Patrick; Oueslati, Ilann; Muscato, Catherine Yildiz; Dahma, Sarah; Blackman, Sydney; De Lissnyder, Nathan

doi:10.1186/s13054-025-05798-6

Xuebijing as a potential therapeutic option for septic shock: the need for rigorous evaluation of life-threatening adverse effects.

Honoré, Patrick

;

Oueslati, Ilann

;

Muscato, Catherine Yildiz

;

Dahma, Sarah

;

De Lissnyder, Nathan

;et.al.

(2025) Critical care (London, England) — Vol. 29, n° 1, p. 522 (2025)

Files

HonoréPCritCare2025.pdf

Open Access
Adobe PDF
677.76 KB

Download

Details

Authors

Honoré, PatrickUCLouvain
Author
Oueslati, Ilann
Author
Muscato, Catherine Yildiz
Author
Dahma, Sarah
Author
Blackman, SydneyUCLouvain
Author
De Lissnyder, Nathan
Author

Affiliations

UCLouvainSSS/IREC/MONT - Pôle Mont Godinne
UCLouvain(MGD) Services des soins intensifs

Citations

APA
Chicago
FWB

Honoré, P., Oueslati, I., Muscato, C. Y., Dahma, S., Blackman, S., & De Lissnyder, N. (2025). Xuebijing as a potential therapeutic option for septic shock: the need for rigorous evaluation of life-threatening adverse effects. Critical care (London, England), 29(1), 522. https://doi.org/10.1186/s13054-025-05798-6 (Original work published 2025)